Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on April 19th, 2012% (USGS.gov)
A spin-off company from University of Minnesota is commercializing a process for generating electricity with geothermal energy from stored carbon dioxide captured at coal-fired power plants. Heat Mining Company LLC, in Rapid City, South Dakota, is based on a technology invented by Minnesota faculty Martin Saar (earth science) and Thomas Kuehn (engineering), . . . → Read More: University Start-Up to Generate Power with Stored CO2
By Alan, on April 19th, 2012% (National Institute on Aging, NIH)
The drug manufacturer Sanofi, based in Paris, and the Michael J. Fox Foundation in New York agreed today to conduct a clinical trial of AVE8112, a Sanofi compound, in patients with Parkinson’s disease. AVE8112 is a type of anti-inflammatory drug known as PDE4 inhibitors that have been tested . . . → Read More: Sanofi, Fox Foundation Partner on Parkinson’s Drug Trial
By Alan, on April 19th, 2012% Alder BioPharmaceuticals Inc. in Bothell, Washington says it closed $38 million in financing today to support clinical studies of its two lead compounds. The series D round, the fourth financing installment after initial start-up, is led by Novo Ventures, the venture capital subsidiary of Danish pharmaceutical maker Novo Nordisk.
Alder BioPharmaceuticals has developed an antibody . . . → Read More: Biotech Company Secures $38 Million Series D Funds
By Alan, on April 19th, 2012% Woven artificial bee silk (CSIRO)
Australia’s Commonwealth Scientific and Industrial Research Organisation (CSIRO) and the global biotechnology company Lonza have agreed to develop new insect silks for medical and industrial applications. Financial and intellectual property terms of the agreement were not disclosed.
Insect silk is a potential component in a range of new . . . → Read More: Australian Science Agency, Biotech Partner on Insect Silks
By Alan, on April 18th, 2012% (CA.gov)
An analysis by researchers in Europe and the U.S. indicate that large-scale biofuel production from forest biomass is unsustainable and will increase greenhouse gas emissions. The findings appear online in the journal Global Change Biology/Bioenergy.
The report, an invited analysis by the journal, was led by the Max-Planck Institute for Biogeochemistry in . . . → Read More: Forest Biofuels Unsustainable, Could Boost Greenhouse Gases
By Alan, on April 18th, 2012% Joseph Wu (Stanford University)
Researchers at the Stanford University School of Medicine in California have devised a process for generating artifical heart cells from the skin of patients with a common cardiac condition. Their findings appear today in the journal Science Translational Medicine (paid subscription required).
The team led by Joseph Wu, a . . . → Read More: Lab-Made Heart Cells Found Useful for Research, Testing
By Alan, on April 18th, 2012% (FEMA.gov)
A study led by researchers at Johns Hopkins University in Baltimore shows helicopter transport increases the survival rate of trauma victims brought to hospitals compared to ground transport, but the costs are high and better guidelines are needed to determine when to use this resource. The findings are published in this week’s . . . → Read More: Helicopter Medevacs Save Trauma Patient Lives But Are Costly
By Alan, on April 18th, 2012% Breakout Labs, a revolving investment fund in San Francisco that aims to support early-stage enterprises developing radical new technologies, announced its first six grants yesterday. The fund is backed by the Thiel Foundation, established by entrepreneur Peter Thiel, a founder of online payments service PayPal and an early investor in Facebook.
All of the recipient . . . → Read More: Breakout Labs Makes First Early-Stage Science Company Grants
By Alan, on April 17th, 2012% Pyrococcus furiosus (Adams Lab, University of Georgia)
Molecular biologists at University of Georgia in Athens have devised a process for engineering a microorganism to generate enzymes at lower temperatures than in its natural state. Their findings appear today in the online journal mBio published by American Society for Microbiology.
The team, led by . . . → Read More: Bioengineered Microbe Developed for Low-Temperature Enzymes
By Alan, on April 17th, 2012% (National Institute of Mental Health)
A clinical trial involving researchers from University of California at San Francisco and the biotechnology company Agenus Inc. in Lexington, Massachusetts found a vaccine has extended the lives of patients with recurrent glioblastoma multiforme, a type of brain cancer. The findings are being presented today at a meeting . . . → Read More: Clinical Trial Shows Brain Cancer Vaccine Extends Lives
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|
You must be logged in to post a comment.